FedEx shares slid 7% before the bell on Wednesday, as a margin squeeze at its core delivery segment raised investor worries about the company's transition following the spinoff of its ‌highly ...
CENTOGENE and Takeda Extend Market Access and Expansion Partnership to Advance Patient Care Globally
Accelerating the path from diagnosis to available treatments for rare metabolic and rare neurodegenerative diseases CENTOGENE and Takeda extend contract to continue providing access to genetic testing ...
RIYADH, Saudi Arabia, July 2, 2023 /PRNewswire/ -- CENTOGENE N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, and Lifera, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results